Monoclonal antibody, hybridoma, polypeptide and method for its preparation, isolated DNA, recombinant vector, host cell, humanized antibody, and pharmaceutical composition
e en provides a monoclonal antibody that specifically targets human interleukin-5. It also provides a hybridoma that produces monoclonal antibody; DNA complement to give variable region and light chain monoclonal antibody and CDRs thereof; humanized monoclonal antibody; and pharmaceutical compositions containing monoclonal antibody for the treatment of losinophilia associated with allergic diseases such as asthma.